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Abela R., Ivanova S., Lidder S., Morris R., Hamilton G. Eur J Vasc Endovasc
Surg 2009;38:666-75.
Objective: Endovascular revascularization in atherosclerotic renal ar-
tery stenosis (ARAS) has dominated during the last 15 years with surgery
relegated mostly to back-up for failed endovascular procedures. This study
examines the available outcome evidence to determine what role open
surgery should have in comparison to endovascular treatment in the man-
agement of ARAS.
Method: Of 183 papers listed in PubMed, the USNLM and the
Cochrane library, (1975–2004) 47, dealing with outcomes of surgical and
endovascular treatments (evidence levels 2b and 3) were selected. Endovas-
cular included 1750 patients in 16 prospective non-randomised (PNRT)
and 5 retrospective (RET) studies. Surgical included 2314 patients in 4
PNRTs and 17 RETs. Outcome data were subjected to meta-regression
analysis weighted according to the inverse variance method.
Results: Mean maximum ages were 79.4 yrs (SD 6.9) for surgical and
83.6 yrs (SD 3.8)for endovascular studies. Primary technical success was
similar. Endovascular patency declined by 0.26%/month (95% CI: 0.04–
0.48, p  0.03). Surgical studies showed greater improvement for hyper-
tension control by 21% (95% CI: 9–33%, p  0.001) and for renal function
by 34% (95% CI: 18–54%, p  0.001), as well as a higher creatinine
reduction by 32 mol/L (95% CI: 7–57 mol/L, p  0.014). A higher
excess surgical mortality, 3.1% (95% CI: 1.8–4.4%, p  0.001) became
insignificant, 0.18% (95% CI: 0.7–1.1, p  0.70) when concomitant aortic
surgery was excluded.
Conclusion: This data shows a marked and durable clinical benefit for
surgery. These findings question the endovascular predominance in inter-
vention in ARAS and highlight the need for a carefully designed prospective
randomised comparison to define the roles of endovascular and surgical
renal revascularization.
Developments in Genomics to Improve Understanding, Diagnosis and
Management of Aneurysms and Peripheral Artery Disease
Tromp G., Kuivaniemi H. Eur J Vasc Endovasc Surg 2009;38:676-82.
Genome-wide approaches, including microarray-based expression pro-
filing, DNA linkage studies and genetic association studies, offer an unbiased
way to identify genetic risk factors and biological processes leading to
discoveries, which might help in the development of new diagnostic and
therapeutic approaches for a wide range of diseases. Currently, the number
of published genome-wide analyses for aneurysms and peripheral artery
diseases is still limited, and it is difficult to generalise about the disease
pathogenesis or genetic risk factors contributing to these diseases. Large
multicentre studies are needed to provide sufficient statistical power, and
replication studies are essential before these findings are used for defining
clinical policies of diagnosis and treatment. The biggest future challenge will
be to translate the genomic information to the clinical settings so that it will
improve our understanding of the disease processes, help us to develop
better diagnostic tools and lead to the design of new ways to manage
aneurysms and peripheral artery disease in the era of personalised medicine.
Characterisation of diseases at the molecular level is likely to lead to more
accurate diagnoses and the use of “genomic nosology” of diseases.
Prognosis of Transient New-Onset Atrial Fibrillation During Vascular
Surgery
Winkel T.A., Schouten O., Hoeks S.E., Verhagen H.J.M., Bax J.J., Polder-
mans D. Eur J Vasc Endovasc Surg 2009;38:683-8.
Background:Chronic atrial fibrillation (AF) in a non-surgical setting is
associated with cardiovascular events. However, the prognosis of transient
new-onset AF during vascular surgery is unknown.
Objective: The purpose of this study is to investigate the prognosis of
new-onset AF during vascular surgery using continuous electrocardio-
graphic monitoring (continuous-ECG).
Methods: In this study, 317 patients, all in sinus rhythm, scheduled for
major vascular surgery were screened for cardiac risk factors. Continuous-
ECG recordings for 72 h and standard ECG on days 3, 7 and 30 were used
to identify new-onset AF. Cardiac troponin T (cTnT) was measured rou-
tinely after surgery. Study endpoint was a composite of cardiac death,myocardial infarction, unstable angina and stroke (cardiovascular events) at
30 days after surgery and during late follow-up. Median follow-up was 12
(interquartile range 2–28) months.
Results: New-onset AF was noted in 15 (4.7%) patients. All but three
patients returned spontaneously to sinus rhythm. The composite endpoint
of cardiovascular events within 30 days and during late follow-up occurred in
34 (11%) and 62 (20%) patients, respectively. Multivariate regression anal-
ysis showed that new-onset AF was associated with perioperative (hazard
ratio (HR) 6.0; 95% CI: 2.4–15) and late cardiovascular events (HR 4.2,
95% CI: 2.1–8.8).
Conclusion: New-onset AF during vascular surgery is associated with
an increased incidence of 30-day and late cardiovascular events.
Management of Inadvertent Arterial Catheterisation Associated with
Central Venous Access Procedures
Pikwer A., Acosta S., Ko¨lbel T., Malina M., Sonesson B., A˚keson J. Eur J
Vasc Endovasc Surg 2009;38:707-14.
Objective: This study aims to describe the clinical management of
inadvertent arterial catheterisation after attempted central venous catheteri-
sation.
Methods: Patients referred for surgical or endovascular management
for inadvertent arterial catheterisation during a 5-year period were identified
from an endovascular database, providing prospective information on tech-
niques and outcome. The corresponding patient records and radiographic
reports were analysed retrospectively.
Results: Eleven inadvertent arterial (four common carotid, six subcla-
vian and one femoral) catheterisations had been carried out in 10 patients.
Risk factors were obesity (n  2), short neck (n  1) and emergency
procedure (n  4). All central venous access procedures but one had been
made using external landmark techniques. The techniques used were stent-
graft placement (n  6), percutaneous suture device (n  2), external com-
pression after angiography (n  1), balloon occlusion and open repair
(n  1) and open repair after failure of percutaneous suture device (n  1).
There were no procedure-related complications within a median follow-up
period of 16 months.
Conclusions: Inadvertent arterial catheterisation during central ve-
nous cannulation is associated with obesity, emergency puncture and lack of
ultrasonic guidance and should be suspected on retrograde/pulsatile cath-
eter flow or local haematoma. If arterial catheterisation is recognised, the
catheter should be left in place and the patient be referred for percutaneous/
endovascular or surgical management.
Conservative Management of Type 2 Endoleaks is not Associated with
Increased Risk of Aneurysm Rupture
Rayt H.S., Sandford R.M., Salem M., Bown M.J., London N.J., Sayers R.D.
Eur J Vasc Endovasc Surg 2009;38:718-23.
Objective: Endovascular repair (EVAR) of abdominal aortic aneu-
rysms (AAAs) has led to a reduction in the perioperative mortality when
compared with open repair. However, re-intervention for complications,
such as endoleak, may be required in up to 20% of the cases. Controversy
exists over the management of Type 2 endoleaks. This study examined the
outcomes of patients with Type 2 endoleaks treated conservatively to inform
the ongoing management debate.
Methods: All patients with a confirmed Type 2 endoleak after EVAR
for an infrarenal AAA were included in the study. Data regarding device
details, endoleak and time point, aneurysm sac growth, intervention and
outcome were collected retrospectively from case notes and the vascular
research database.
Results: Forty-one Type 2 endoleaks were seen in 369 EVARs per-
formed for infrarenal AAA between March 1994 and June 2006. Twenty-
five were isolated Type 2 endoleaks and 16 occurred in conjunction with
other endoleaks. Of the 25 isolated Type 2 endoleaks, 18 (72%) patients
demonstrated no increase in sac size, six (24%) patients showed an enlarge-
ment of the sac and one patient was lost to follow-up. Only one patient
underwent intervention for an isolated Type 2 endoleak. After a mean
follow-up period of 4 years, approximately half of the patients (48%) remain
under observation (with an enlarging or stable sac), whilst the others (48%)
have spontaneously sealed. Only five patients under surveillance (20%) have
an enlarging sac. There were no ruptured aneurysms or aneurysm-related
deaths and no patients required conversion to open repair.
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